Teva Pharmaceutical Industries Ltd. ADR 26.47% $18.82B ...

GSK has upgraded its longstanding alliance ... and the Medicines Patent Pool (MPP), revolving around a central manufacturing hub in South Africa. Eli Lilly has another approval for its anti ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in Singapore. GSK inked an antibody-drug conjugate deal with DualityBio and ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...

GSK’s liner­ix­i­bat helped re­duce itch in pa­tients with an au­toim­mune liv­er dis­ease that af­fects the bile ducts, meet­ing its pri­ma­ry end­point in a late-stage tri­al … ...